Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
Clinical trial NCT02659293 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02659293
- Sponsor
- University of Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-26
- Primary completion
- 2027-11-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.